MDL Sought By Belviq Weight Loss Drug Patients Due To Cancer Risk

Mealey's (May 4, 2021, 3:34 PM EDT) -- WASHINGTON, D.C. — Thirteen plaintiffs on April 12 filed a petition asking the Judicial Panel on Multidistrict Litigation (JPMDL) to centralize federal lawsuits of plaintiffs who allege that they developed cancer or are at risk of developing cancer after taking the now-withdrawn prescription weight-loss drug Belviq....

Related Sections